Advanced Contrast Agents Aim To Improve Cost, Convenience Of Cardiac Imaging
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Diagnosis of cardiovascular disease could become less costly and invasive if the alternatives to nuclear imaging and X-ray angiography that dominate the late-stage imaging agent pipeline live up to their promise.